Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis-Reference-Cited by-同舟云学术

Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis

Published:2023 Issue:12 Volume:19 Page:3678-3693
ISSN:1449-2288
Container-title:International Journal of Biological Sciences
language:en
Short-container-title:Int. J. Biol. Sci.

Author:

Cao Mingbo,Ren Yupeng,Li Yuxuan,Deng Junfeng,Su Xiaorui,Tang Yongchang,Yuan Feng,Deng Haixia,Yang Gaoyuan,He Zhiwei,Liu Bo,Yao Zhicheng,Deng Meihai

Publisher

Ivyspring International Publisher

Subject

Cell Biology,Developmental Biology,Molecular Biology,Applied Microbiology and Biotechnology,Ecology, Evolution, Behavior and Systematics

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism;Computers in Biology and Medicine;2024-09

2. New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma;Drug Discovery Today;2024-08

3. GDF11 inhibits the malignant progression of hepatocellular carcinoma via regulation of the mTORC1‑autophagy axis;Experimental and Therapeutic Medicine;2024-04-15

4. Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects;Frontiers in Bioscience-Landmark;2024-02-04

5. Upregulation of LncRNA-LHX2 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion and Metastasis via Targeting VEGFA by Sequestering of MiR-939-5p;Journal of Biomedical Nanotechnology;2024-02-01